Papers
1
Total Citations
7
H-Index
1
About
Dr. John Pang is a leading surgical oncologist whose research focuses on refining treatment strategies for head and neck cancers, particularly oropharyngeal squamous cell carcinoma (OPSCC). His major contributions center on improving surgical precision and multidisciplinary decision-making, most notably through his work on margin status interpretation following transoral robotic surgery (TORS). In his highly cited 2023 study, Dr. Pang demonstrated critical discrepancies between pathology reports and multidisciplinary tumor board assessments of surgical margins for p16-positive OPSCC, directly impacting adjuvant therapy decisions and patient outcomes. This work has garnered 7 citations in just one year, reflecting its immediate clinical relevance. By highlighting the need for collaborative evaluation, Dr. Pang’s research helps reduce unnecessary overtreatment while ensuring clear margins are achieved. His findings are shaping best practices in robotic head and neck surgery, making him a key voice in the ongoing effort to personalize care for HPV-related oropharyngeal cancers.
Research Focus
Key Achievements
Top Papers
- 1